Pantozol Control (Pantoprazole)

Pantoprazole, the active ingredient in Pantozol Control, is a proton pump inhibitor presented as an oral tablet for oral use. It treats acid‑related disorders such as gastro‑oesophageal reflux disease, erosive oesophagitis, peptic ulcer disease and Zollinger‑Ellison syndrome in adult patients.

GNH USA supplies Pantozol Control as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is used to manage acid‑related disorders by reducing gastric acid secretion.

- Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive oesophagitis: heals erosive lesions and helps prevent recurrence. - Peptic ulcer disease: accelerates ulcer healing and lowers the risk of re‑bleeding. - Zollinger‑Ellison syndrome: controls excessive gastric acid production.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: watery stools, usually transient. - Abdominal pain: discomfort or cramping. - Nausea: feeling of unease or urge to vomit. - Flatulence: excess gas in the gastrointestinal tract. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, anaphylaxis. - Clostridioides difficile infection: severe colitis with diarrhoea. - Hypomagnesemia: low magnesium levels, may cause muscle cramps. - Liver enzyme elevation: increased ALT/AST indicating hepatic stress. - Pancreatitis: inflammation of the pancreas, presenting with abdominal pain.

When prescribing Pantoprazole, consider the following safety measures.

- Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. - Breastfeeding: weigh maternal benefit against possible infant exposure. - Elderly patients: monitor for dehydration and electrolyte disturbances. - Concomitant warfarin therapy: observe INR closely for possible elevation. - Long‑term use: assess for vitamin B12 deficiency and bone mineral density loss. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Pantoprazole may interact with several medicines; some require avoidance while others need careful monitoring.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir: decreased absorption, leading to sub‑therapeutic antiviral levels. - High‑dose methotrexate: increased toxicity due to reduced renal clearance.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation parameters. - Digoxin: possible rise in serum digoxin concentrations. - Diazepam: may elevate plasma levels, watch for enhanced sedation.